Abstract:Purpose Although MYBL2 had been validated to participate in multiple cancers including leukemia, the role of MYBL2 polymorphisms in acute lymphoblastic leukemia (ALL) was still not clear. In this study, we aimed to evaluate the association between MYBL2 single nucleotide polymorphisms (SNPs) and ALL risk in children. Methods A total of 687 pediatric ALL cases and 971 cancer-free controls from two hospitals in South China were recruited. A case-control study by genotyping three SNPs in the MYBL2 gene (rs285162 C>T, rs285207 A>C, and rs2070235 A>G) was conducted. The associations were assessed by odds ratios (ORs) with corresponding 95% confidence intervals (CIs). Subgroup and stratification analyses were conducted to explore the association of rs285207 with ALL risk in terms of age, sex, immunophenotype, risk level, and other clinical characteristics. The false-positive report probability (FPRP) analysis was performed to verify each significant finding. Functional analysis in silico was used to evaluate the probability that rs285207 might influence the regulation of MYBL2 . Results Our study demonstrated that rs285207 was related to a decreased ALL risk (adjusted OR = 0.78; 95% CI = 0.63-0.97, P = 0.022) in the dominant model. The associations of rs285207 with ALL risk appeared stronger in patients with pre B ALL (adjusted OR=0.56; 95% CI=0.38-0.84, P =0.004), with normal diploid (adjusted OR=0.73; 95% CI=0.57-0.95, P =0.017), with low risk (adjusted OR=0.68; 95% CI=0.49-0.94, P =0.021), with lower WBC (adjusted OR=0.62; 95% CI=0.43-0.87, P =0.007) or lower platelet level (adjusted OR=0.76; 95% CI=0.59-0.96, P =0.023). With FPRP analysis, the significant association between the rs285207 polymorphism and decreased ALL risk was still noteworthy (FPRP=0.128). Functional analysis showed that IKZF1 bound to DNA motif overlapping rs285207 and had a higher preference for the risk allele A. As for rs285162 C>T and rs2070235 A>G, no significant was found between them and ALL risk. Conclusion In this study, we revealed that rs285207 polymorphism decreased the ALL risk in children, and rs285207 might alter the binding to IKZF1, which indicated that the MYBL2 gene polymorphism might be a potential biomarker of childhood ALL.

Association of Janus Kinase 2 (JAK2) Polymorphisms with Acute Leukemia Susceptibility.

Association of Janus Kinase 2(jak2) A830g Polymorphism with Acute Leukemia Susceptibility.

Investigation and Analysis of Single Nucleotide Polymorphisms in Janus Kinase/Signal Transducer and Activator of Transcription Genes with Leukemia

The Associations of Janus Kinase-2 (jak2) A830g Polymorphism and the Treatment Outcomes in Patients with Acute Myeloid Leukemia

The polymorphism of JAK2 rs56118985 may be a predictive marker of the treatment responses of acute myeloid leukemia patients

Effect of Polymorphism on IL1A to Cancer Susceptibility: Evidence Based on 34,016 Subjects

KLK2 single-nucleotide polymorphism rs198977 is associated with increased susceptibility and hyperleukocytosis in AML

Signal Transducer and Activator of Transcription 3 (STAT3) Gene Polymorphisms Are Associated with Treatment Outcomes in Acute Myeloid Leukemia

Molecular basis of JAK2 H608Y and H608N mutations in the pathology of acute myeloid leukemia

The Activator of Transcription 3 (STAT3) Gene Polymorphisms Are Associated with Treatment Outcomes In Acute Myeloid Leukemia

Loss of K607 and E877 interaction is a key reason for JAK2 K607N mutation caused acute myeloid leukemia.

Disruption of R867 and Y613 Interaction Plays Key Roles in JAK2 R867Q Mutation Caused Acute Leukemia.

The Effects of R683S (G) Genetic Mutations on the JAK2 Activity, Structure and Stability.

Immunorelated Gene Polymorphisms Associated with Acute Myeloid Leukemia

MYBL2 Gene Polymorphism Is Associated With Acute Lymphoblastic Leukemia Susceptibility in Children

Association of Genetic Polymorphism of XRCC1 with Susceptibility to Acute Childhood Leukemia

Janus Kinase 2 Variants Associated with the Transformation of Myeloproliferative Neoplasms into Acute Myeloid Leukemia

IL-8 –251A/T Polymorphism is Associated with Decreased Cancer Risk among Population-Based Studies: Evidence from a Meta-Analysis

Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia

JAK2 Rs10758669 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: a Meta-Analysis.

The Rs9909659g/A Polymorphisms of the Stat3 Gene Provide Prognostic Information in Acute Myeloid Leukemia